Pinelopi Arvaniti

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Kalliopi Zachou, Nikolaos Gatselis, Pinelopi Arvaniti et al. · Alimentary Pharmacology & Therapeutics · 2016 · 109 citations · Full text

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis

Pinelopi Arvaniti, George Giannoulis, Stella Gabeta et al. · JHEP Reports · 2020 · 58 citations · Full text

Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis

Kalliopi Zachou, Pinelopi Arvaniti, Kalliopi Azariadis et al. · Hepatology Research · 2018 · 54 citations · Full text

Liver Fibrosis, Immunodeficiencies, Immunology +24

JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren’s Syndrome

Amandine Charras, Pinelopi Arvaniti, Christelle Le Dantec et al. · Clinical Reviews in Allergy & Immunology · 2019 · 54 citations

Rheumatology, Allergy, Autoimmune Disease +9

JAK Inhibitors and Oxidative Stress Control

Amandine Charras, Pinelopi Arvaniti, Christelle Le Dantec et al. · Frontiers in Immunology · 2019 · 53 citations · Full text